Donald Trump's health care plan would retain the status quo
The Republican Party is still having difficulty formulating concrete health care proposals
During the televised debate between Republican Donald Trump and Democrat Kamala Harris on Sept. 10, Trump was unable to respond to moderators pressing him for details on his plan to replace the Affordable Care Act (ACA). "I have concepts of a plan," Trump said, inviting widespread ridicule.
But Trump was telling the truth — neither he nor his party have released a health care plan since their efforts to repeal the ACA fell apart early in Trump's presidency. The U.S. health care system is both extraordinarily complex and deeply resistant to change, and the Trump campaign appears to be gambling that voters would mostly prefer the status quo to any significant reforms.
A focus on pharmaceuticals
Trump's policy blueprints are compiled on a section of his website labeled Agenda 47. One item is dedicated to drugs and drug prices. The former president continues to promise lower Medicare drug prices, although details are sparse. His campaign has also pledged to tackle a shortage of certain critical drugs by bringing their production back to the United States. The campaign assails "the extreme national vulnerability caused by the lack of an adequate domestic manufacturing capability for critical pharmaceuticals" and promises to ramp up domestic production. It is an assessment that is shared by a 2023 report produced by the Senate Homeland Security and Governmental Affairs Committee.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Trump is critical of U.S. reliance on drugs exported from China. And drug shortages, particularly those used to treat diabetes, as well as some cancers, are a real problem. "A significant majority of the ingredients in the drugs people take in the U.S. are produced overseas, mostly in China and India," said Jen Christensen at CNN. Trump says he will take executive action to address the problem by supporting U.S. manufacturers.
Vague promises about bigger changes
Apart from drugs and drug prices, the Trump campaign is not openly campaigning behind health care ideas. While Republican-aligned think tanks have certainly offered proposals to reform the health care system, the party itself has been unwilling or unable to go on record with concrete specifics in recent years. "Republicans will increase Transparency, promote Choice and Competition, and expand access to new Affordable Healthcare and prescription drug options," said the 2024 Republican Party platform in its only effort to address the issue.
The uncertainty was also reflected in remarks by the GOP's vice presidential candidate, Sen. J.D. Vance (R-Ohio), speaking about health care during his Oct. 1 debate with Democratic vice presidential nominee Gov. Tim Walz (D-Minn.). The campaign hasn't released policy details about health care because "you're not going to propose a 900 page bill standing on a debate stage," said Vance. Reforms would happen, instead, as part of "the give and take of bipartisan negotiation." Vance talked about how it does not make sense to force younger, healthier people into the same risk pools as older Americans with more expensive needs. "We're going to actually implement some regulatory reform in the health care system that allows people to choose a health care plan that works for them," Vance said at a September rally in Raleigh, North Carolina.
Competing interpretations of the Trump-Vance plan
The Trump campaign says it will protect Medicare funding, and both Trump and Vance have promised to protect Americans with preexisting conditions. However, critics have noted that Vance's comments about separating sick from healthy Americans sound ominously like a return to the days before the Affordable Care Act was passed. "This would appear to roll back some of the Affordable Care Act, which got rid of insurance companies' ability to deny coverage based on preexisting conditions," said Hafiz Rashid at The New Republic.
Not everyone shares that assessment. "The reforms recommended by Senator Vance would protect people with preexisting conditions and give people better health-coverage options, aims that are not mutually exclusive," said Brian Blase at the National Review. But unless the Trump campaign releases a policy blueprint, it will likely have a hard time settling these disagreements about the intent and outcomes of their ideas.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
David Faris is an associate professor of political science at Roosevelt University and the author of It's Time to Fight Dirty: How Democrats Can Build a Lasting Majority in American Politics. He is a frequent contributor to Informed Comment, and his work has appeared in the Chicago Sun-Times, The Christian Science Monitor, and Indy Week.
-
US sanctions Israeli West Bank settler group
Speed Read The Biden administration has imposed sanctions on Amana, Israel's largest settlement development organization
By Rafi Schwartz, The Week US Published
-
Gaetz ethics report in limbo as sex allegations emerge
Speed Read A lawyer representing two women alleges that Matt Gaetz paid them for sex, and one witnessed him having sex with minor
By Peter Weber, The Week US Published
-
Today's political cartoons - November 19, 2024
Cartoons Tuesday's cartoons - junk food, health drinks, and more
By The Week US Published
-
Gaetz ethics report in limbo as sex allegations emerge
Speed Read A lawyer representing two women alleges that Matt Gaetz paid them for sex, and one witnessed him having sex with minor
By Peter Weber, The Week US Published
-
The clown car cabinet
Opinion Even 'Little Marco' towers above his fellow nominees
By Mark Gimein Published
-
What Mike Huckabee means for US-Israel relations
In the Spotlight Some observers are worried that the conservative evangelical minister could be a destabilizing influence on an already volatile region
By Rafi Schwartz, The Week US Published
-
The Pentagon faces an uncertain future with Trump
Talking Point The president-elect has nominated conservative commentator Pete Hegseth to lead the Defense Department
By Justin Klawans, The Week US Published
-
'All Tyson-Paul promised was spectacle and, in the end, that's all we got'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Can Europe pick up the slack in Ukraine?
Today's Big Question Trump's election raises questions about what's next in the war
By Joel Mathis, The Week US Published
-
What does the G20 summit say about the new global order?
Today's Big Question Donald Trump's election ushers in era of 'transactional' geopolitics that threatens to undermine international consensus
By Elliott Goat, The Week UK Published
-
What will Trump mean for the Middle East?
Talking Point President-elect's 'pro-Israel stance' could mask a more complex and unpredictable approach to the region
By Chas Newkey-Burden, The Week UK Published